April 24, 2022

Emendo Biotherapeutics to present at the American Society of Gene & Cell Therapy annual conference

Conference More
April 17, 2022

Emendo Biotherapeutics to present at upcoming BioMed 2022

Conference More
December 16, 2021

CRISPR innovation hits the gas

Biocentury More
January 15, 2020

Emendo Eyes the Clinic for CRISPR Therapy That Makes Single-Gene Edits

Xconomy More
January 15, 2020

Fifth Emendo-ment: Next-wave gene editing process gets its due, eminent in domain as more board the Omni-bus

Bio World More
January 15, 2020

Emendo Biotherapeutics Nabs $61M for “Next-Generation CRISPR” R&D

Xconomy More
January 15, 2020

Takeda hops onto $61M round for CRISPR player synthesizing Cas9 alternatives

Endpoint News More
January 15, 2020

Emendo raises $61M to build on Takeda-partnered gene editing platform

FierceBiotech More
close